The NHS is currently facing supply issues with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a range of drugs used for managing blood glucose levels in people with type 2 diabetes.
We are currently working on this section.
The NHS is currently facing supply issues with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a range of drugs used for managing blood glucose levels in people with type 2 diabetes.
We are currently working on this section.